ATRC - Latest News
AtriCure, Inc. (ATRC), operates in Healthcare / Medical - Instruments & Supplies, trades on NASDAQ.
Market capitalization stands near $1.53B. Beta to the broader market is 1.26.
The article list below shows the most recent ATRC headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent ATRC Headlines
AtriCure (ATRC) Soars 6.2%: Is Further Upside Left in the Stock?
zacks.com - Jun 19, 2026
AtriCure (ATRC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the
Do Options Traders Know Something About AtriCure Stock We Don't?
zacks.com - Jun 11, 2026
Investors need to pay close attention to ATRC stock based on the movements in the options market lately.
AtriCure, Inc. (ATRC) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
seekingalpha.com - Jun 10, 2026
AtriCure, Inc.
AtriCure to Participate in the Goldman Sachs 47th Annual Global Health Care Conference
businesswire.com - May 27, 2026
MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib),
AtriCure to Participate in the Goldman Sachs 47th Annual Global Health Care Conference
gurufocus.com - May 27, 2026
[url="]AtriCure, Inc.
How News Affects ATRC Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track ATRC's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked ATRC news questions
- What is the latest ATRC news headline?
- The most recent ATRC headline (Jun 19, 2026) is "AtriCure (ATRC) Soars 6.2%: Is Further Upside Left in the Stock?". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the ATRC news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What ATRC news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual ATRC options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.